TipRanks on MSN3h
Sichuan Kelun-Biotech Gains Approval for SKB571 TrialsSichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update. Sichuan Kelun-Biotech ...
The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...
VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
Vaccine stocks slid on the news. RAHWAY, N.J., November 15, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s ...
Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback